193 related articles for article (PubMed ID: 8630187)
1. Photolysis of an iodoplatinum(IV) diamine complex to cytotoxic species by visible light.
Kratochwil NA; Bednarski PJ; Mrozek H; Vogler A; Nagle JK
Anticancer Drug Des; 1996 Mar; 11(2):155-71. PubMed ID: 8630187
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and X-ray crystal structure of trans,cis-[Pt(OAc)2I2(en)]: a novel type of cisplatin analog that can be photolyzed by visible light to DNA-binding and cytotoxic species in vitro.
Kratochwil NA; Zabel M; Range KJ; Bednarski PJ
J Med Chem; 1996 Jun; 39(13):2499-507. PubMed ID: 8691447
[TBL] [Abstract][Full Text] [Related]
3. Studies on the photoactivation of two cytotoxic trans,trans,trans-diazidodiaminodihydroxo-Pt(IV) complexes.
Westendorf AF; Bodtke A; Bednarski PJ
Dalton Trans; 2011 May; 40(19):5342-51. PubMed ID: 21461431
[TBL] [Abstract][Full Text] [Related]
4. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
[TBL] [Abstract][Full Text] [Related]
5. Photoactivatable platinum complexes.
Bednarski PJ; Mackay FS; Sadler PJ
Anticancer Agents Med Chem; 2007 Jan; 7(1):75-93. PubMed ID: 17266506
[TBL] [Abstract][Full Text] [Related]
6. A photoactivated trans-diammine platinum complex as cytotoxic as cisplatin.
Mackay FS; Woods JA; Moseley H; Ferguson J; Dawson A; Parsons S; Sadler PJ
Chemistry; 2006 Apr; 12(11):3155-61. PubMed ID: 16470886
[TBL] [Abstract][Full Text] [Related]
7. Rapid reduction of tetrachloro(D,L-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in RPMI 1640 tissue culture medium.
Gibbons GR; Wyrick S; Chaney SG
Cancer Res; 1989 Mar; 49(6):1402-7. PubMed ID: 2924297
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of metal-metal coupling at a considerable distance by using 4-pyridinealdazine as a bridging ligand in polynuclear complexes of rhenium and ruthenium.
Cattaneo M; Fagalde F; Katz NE; Leiva AM; Schmehl R
Inorg Chem; 2006 Jan; 45(1):127-36. PubMed ID: 16390048
[TBL] [Abstract][Full Text] [Related]
9. Theoretical analysis on the transition state of the anticancer drug trans-[PtCl2(isopropylamine)2] and its cis isomer binding to DNA purine bases.
Zhou L
J Phys Chem B; 2009 Feb; 113(7):2110-27. PubMed ID: 19173577
[TBL] [Abstract][Full Text] [Related]
10. Syntheses, characterization, and photo-hydrogen-evolving properties of tris(2,2'-bipyridine)ruthenium(II) derivatives tethered to a cis-Pt(II)Cl2 unit: insights into the structure-activity relationship.
Ozawa H; Yokoyama Y; Haga MA; Sakai K
Dalton Trans; 2007 Mar; (12):1197-206. PubMed ID: 17353951
[TBL] [Abstract][Full Text] [Related]
11. cis-[PtCl2(4,7-H-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine)2]: a sterically restrictive new cisplatin analogue. Reaction kinetics with model nucleobases, DNA interaction studies, antitumor activity, and structure-activity relationships.
Navarro JA; Salas JM; Romero MA; Vilaplana R; Gonzalez-Vílchez F; Faure R
J Med Chem; 1998 Jan; 41(3):332-8. PubMed ID: 9464364
[TBL] [Abstract][Full Text] [Related]
12. Photolysis and thermolysis of platinum(IV) 2,2'-bipyridine complexes lead to identical platinum(II)-DNA adducts.
Loup C; Tesouro Vallina A; Coppel Y; Létinois U; Nakabayashi Y; Meunier B; Lippert B; Pratviel G
Chemistry; 2010 Oct; 16(37):11420-31. PubMed ID: 20715200
[TBL] [Abstract][Full Text] [Related]
13. Relationships between reduction properties and cancer cell growth inhibitory activities of cis-dichloro- and cis-diiodo-Pt(IV)-ethylenediamines.
Kratochwil NA; Bednarski PJ
Arch Pharm (Weinheim); 1999 Aug; 332(8):279-85. PubMed ID: 10489538
[TBL] [Abstract][Full Text] [Related]
14. Platinum(IV) analogues of AMD473 (cis-[PtCl2(NH3)(2-picoline)]): preparative, structural, and electrochemical studies.
Battle AR; Choi R; Hibbs DE; Hambley TW
Inorg Chem; 2006 Aug; 45(16):6317-22. PubMed ID: 16878941
[TBL] [Abstract][Full Text] [Related]
15. Reduction of cis,trans,cis-[PtCl2(OCOCH3)2(NH3)2] by aqueous extracts of cancer cells.
Nemirovski A; Kasherman Y; Tzaraf Y; Gibson D
J Med Chem; 2007 Nov; 50(23):5554-6. PubMed ID: 17949066
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, X-ray crystallographic, and NMR characterizations of platinum(II) and platinum(IV) pyrophosphato complexes.
Mishur RJ; Zheng C; Gilbert TM; Bose RN
Inorg Chem; 2008 Sep; 47(18):7972-82. PubMed ID: 18693681
[TBL] [Abstract][Full Text] [Related]
17. Effect of thiols exported by cancer cells on the stability and growth-inhibitory activity of Pt(IV) complexes.
Kratochwil NA; Bednarski PJ
J Cancer Res Clin Oncol; 1999 Dec; 125(12):690-6. PubMed ID: 10592102
[TBL] [Abstract][Full Text] [Related]
18. Decomposition pathways for the photoactivated anticancer complex cis,trans,cis-[Pt(N3)2(OH)2(NH3)2]: insights from DFT calculations.
Salassa L; Phillips HI; Sadler PJ
Phys Chem Chem Phys; 2009 Nov; 11(44):10311-6. PubMed ID: 19890514
[TBL] [Abstract][Full Text] [Related]
19. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization and cytotoxic activity of substituted benzyl iminoether Pt(II) complexes of the type cis- and trans-[PtCl2{E-N(H)=C(OMe)CH2-C6H4-p-R}2] (R=Me, OMe, F). X-ray structure of trans-[PtCl2{E-N(H)=C(OMe)CH2-C6H4-p-F}2].
Mazzega Sbovata S; Bettio F; Marzano C; Tassan A; Mozzon M; Bertani R; Benetollo F; Michelin RA
J Inorg Biochem; 2008 Apr; 102(4):882-91. PubMed ID: 18267343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
